Merck Launches New Addition to the Circumvent G2 Product Line
US - Merck Animal Health last week introduced Circumvent® PCV-M G2 - a porcine circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae combination vaccine. The new vaccine is the only one-dose or two-dose, ready-to-use combination with five-month PCV2 duration of immunity, which is 25 percent longer than any other PCV2 vaccine on the market.
23 January 2014
2 minute read
